Axon said it intends to offer, subject to market and other conditions, a total of $1,500.0 million in senior notes, consisting of notes due 2030 and notes due 2033. The offering is expected to be launched on March 5, 2025.

1. 01

   Axon said it intends to offer, subject to market and other conditions, a total of $1,500.0 million in senior notes, consisting of notes due 2030 and notes due 2033. The offering is expected to be launched on March 5, 2025.

2. 02

   The company said the notes will be sold in a private placement exempt from Securities Act registration requirements, only to qualified institutional buyers under Rule 144A in the United States and to non-U.S. persons under Regulation S outside the United States.

3. 03

   The company said it plans to use the net proceeds for general corporate purposes, which may include repurchasing or redeeming its 0.50% Convertible Senior Notes due 2027, supporting growth, and acquiring or investing in product lines and technologies.

4. 04

   The company expects to enter into an amendment to its credit agreement in connection with the offering. The amendment would increase the revolving credit facility by $100.0 million to $300.0 million and extend the maturity from December 15, 2027 to five years from the closing of the amendment.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.